Drug Profile
PF 431499
Alternative Names: PF-431499Latest Information Update: 22 Aug 2007
Price :
$50
*
At a glance
- Originator Pfizer
- Class Obesity therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Obesity
Most Recent Events
- 31 Jul 2007 Discontinued - Phase-I for Obesity in USA (unspecified route)